Cohorts

Female Woman Hospital Doctor Looking at X-Rays iStock 000021247551Small European Prosthetic Joint Infection Cohort (EPJIC) is an international project including 5000 patients with prosthetic joint infection (PJI) to evaluate the long-term outcome regarding infection, function and life-quality. A global databank and collection of clinical isolates and other biological samples will be established for further research (biobank). 

EPJIC is established jointly by orthopedic and traumatology surgeons, infectious diseases specialists and microbiologists and is endorsed by leading European societies. Patients will be recruited in about 100 university and non-university institutions across Europe and other continents.

Other European cohorts (in the process of establishment):

  • Osteomyelitis
  • Arthritis
  • Vetrebral Osteomyelitis
  • Breast Implant Infection
  • Intravascular Device Infections
  • Vascular Prosthesis Infection
  • Neurosurgical Implant Infection
  • Dental Implant Infection

More...

Consultation Service

PIF CS icon 110

Online consultation service for bone, joint and implant-associated infections.

ACCESS PORTAL

 

DOWNLOAD FLYER

Workshops

Prosthetic Joint Infection

  •  September 4-5, 2017
  •  December 11-12, 2017
  •  April 9-10, 2018
  •  June 25-26, 2018
  •  September 27-28, 2018
  •  December 13-14, 2018

REGISTER WS PJI NOW!

Infections after Fracture Fixation

  •  January 12, 2018
  •  May 25, 2018

REGISTER WS IFF NOW!

Pocket Guide: Diagnosis & Treatment of PJI & PII

Order PJI or PII 

Order Pocket Guide in different languages.
Price: from 8 €

 DIAGNOSIS & TREATMENT OF PJI

 DIAGNOSIS & TREATMENT OF PII

Handbook: Infections of the Musculoskeletal System

eng de small

Order the Handbook free of charge now:

PRO-IMPLANT Foundation Materials

Become a registered user free of charge

Ideas, Suggestions?

Please share your ideas or suggestions for our work.

Click here

Supporters

MSD
ZimmerBiomet
ceramtec
Bonesupport Logo Large
aposan
Origimm
BonAlive
Basilea
Roche
diaxnohit
debiopharm
riemser pharma